In 2014, the FDA amended its regulations governing the content and format of labeling for human prescription drugs and biological products.65 The amendment, which became effective on 30 June 2015, required the removal of the old pregnancy categories A, B, C, D, and X from all drug product labeling. Information about LA-related risks to the fetus and recommendations about the use of LAs during pregnancy can now be found in the new “Pregnancy” subsection of specific package inserts.21-25
Your session is about to expire. Do you want to continue logged in?
WARNING! You did not finish creating your certificate. Please click CONTINUE below to return to your previous page to complete the process. Failure to complete ALL the steps will result in a loss of this test score, and you will not receive credit for this course.